|Day Low/High||8.83 / 9.73|
|52 Wk Low/High||8.45 / 36.65|
NEW YORK, May 22, 2019 /PRNewswire/ -- Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Mallinckrodt plc (NYSE: MNK) common stock from April 13, 2016 through May 21, 2019.
Mallinckrodt plc shares have declined by nearly 38% in 2019 due to issues with health regulators and accusations of kickbacks.
-- New member brings unique blend of industry expertise and clinical experience --
The drugmaker files suit against the U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services in order to protect Medicaid patient access to its Acthar gel.
-- Company challenges CMS' unexplained and unlawful reversal of its repeated 2012 written authorizations on calculation of Medicaid Rebates for Acthar Gel --
BMY is not 'out of the woods' yet, but aggressive traders could probe the long side here.
Jim Cramer says this market is influenced by tariffs and trade talks -- with the Federal Reserve and the economy playing second fiddle.
Jim Cramer takes a look at Applied Materials, HP, Lam Research, Schlumberger, PBF Energy, Targa Resources, Mallinckrodt and more.
Investors in Mallinckrodt plc saw new options begin trading today, for the June 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNK options chain for the new June 28th contracts and identified one put and one call contract of particular interest.
-- Mallinckrodt's CONFIRM study is evaluating the efficacy and safety of terlipressin in hepatorenal syndrome type 1 --
NEW YORK, May 13, 2019 /PRNewswire/ -- Glencore plc (GLNCY) Lifshitz & Miller announces investigation into possible securities laws violations regarding allegations that GLNCY and other trading firms paid over $30 million in bribes to Petroleo Brasieiro S.
- Net sales up 4.7%, or 5.0% on a constant-currency basis, on $790.6 million, led by strong performance of hospital products and the Specialty Generics and Amitiza segment
-- Full data to be presented in detail by CPP at Digestive Disease Week (DDW) conference on May 19, 2019 at 5:19 pm Pacific Time --
-- Observational registry (at midway point) with retrospective data collection provides preliminary evaluation of premature versus term and near-term neonates with pulmonary hypertension receiving inhaled nitric oxide --
SAN DIEGO, May 2, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP has commenced an investigation into whether certain officers and directors of Mallinckrodt PLC (NYSE: MNK) violated federal laws.
Investors in Mallinckrodt plc saw new options become available today, for the June 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNK options chain for the new June 14th contracts and identified one put and one call contract of particular interest.
-- Company also announces completion of controlled, double-blind, randomized phase (n=154; open-label phase, n=259) of multicenter study -
Investors in Mallinckrodt plc saw new options begin trading today, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNK options chain for the new June 21st contracts and identified one put and one call contract of particular interest.
- Expanded state-of-the-art facility provides capacity for clinical and commercial development of StrataGraft, if approved -
-- Company continues focus on evidence expansion, potential utility of Acthar Gel in appropriate, underserved patients --
-- Study showed oxygenation improvement and increased out-of-body perfusion duration --
-- Retrospective analysis showed applying latest International Club of Ascites (ICA) diagnostic criteria would be estimated to result in earlier time to treatment at a lower SCr level and potentially improved outcomes --
-- Pivotal Phase 3 study is evaluating efficacy and safety of investigational regenerative skin tissue in adults with deep partial-thickness burns --
-- Discovery program aimed at identifying potential new drugs targeting chronic itch, a serious condition spanning multiple disorders --
-- Physicians report improved overall disease status in 84 percent of patients after Acthar Gel therapy --
-- Company earns 100 percent on Human Rights Campaign Foundation's 17th annual scorecard on LGBTQ Workplace Equality --
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.